BENEFICIAL EFFECTS OF LIRAGLUTIDE ON ATHEROGENIC SMALL, DENSE LOW-DENSITY LIPOPROTEINS IN PATIENTS WITH TYPE-2 DIABETES: A 2-MONTH PROSPECTIVE PILOT STUDY

被引：0
|
作者：
Nikolic, D. [1 ]
Rizzo, M. [1 ]
Giglio, R. V. [1 ]
Di Bartolo, V. [1 ]
Ferlita, A. [1 ]
Zabbara, A. [1 ]
Tamburello, A. [1 ]
Giannone, V. [1 ]
Montalto, G. [1 ]
Rizvi, A. A. [2 ]
机构：
[1] Univ Palermo, Biomed Dept Internal Med & Med Specialties, Palermo, Italy
[2] Univ S Carolina, Sch Med, Div Endocrinol Diabet & Metab, Columbia, SC USA
来源：
CARDIOLOGY | 2013年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 289
页数：1
相关论文
共 50 条
  • [41] Association of Very Low-density Lipoprotein Cholesterol With Coronary Artery Calcification in Type-2 Diabetes
    Prenner, Stuart B.
    Mulvey, Claire K.
    Qasim, Atif N.
    Bhatt, Anish
    Terembula, Karen
    Iqbal, Nayyar
    Reilly, Muredach P.
    CIRCULATION, 2013, 128 (22)
  • [42] THE SIGNIFICANCE OF OXIDIZED LOW-DENSITY LIPOPROTEINS AND RECEPTORS LOX-1 IN TYPE 2 DIABETES MELLITUS
    Fetlam, Dmitry L.
    Chumachenko, Anastasya G.
    Pisarev, Vladimir M.
    DIABETES MELLITUS, 2024, 27 (06): : 589 - 597
  • [43] Oxidability of low density lipoproteins in patients with type 2 diabetes: Relationship with LDL glycosylation
    Moro, E
    Zambon, C
    Pianetti, S
    Cazzolato, G
    Bon, GB
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 312 - 313
  • [44] Prospective randomized comparative study of the effect of pemafibrate add-on or double statin dose on small dense low-density lipoprotein-cholesterol in patients with type 2 diabetes and hypertriglyceridemia on statin therapy
    Hirano, Tsutomu
    Hayashi, Toshiyuki
    Sugita, Hiroe
    Tamasawa, Atsuko
    Goto, Satoshi
    Tomoyasu, Masako
    Yamamoto, Takeshi
    Ohara, Makoto
    Terasaki, Michishige
    Kushima, Hideki
    Ito, Yasuki
    Yamagishi, Sho-ichi
    Mori, Yusaku
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (12) : 1401 - 1411
  • [45] Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
    Hayashi, Toshiyuki
    Fukui, Tomoyasu
    Nakanishi, Noriko
    Yamamoto, Saki
    Tomoyasu, Masako
    Osamura, Anna
    Ohara, Makoto
    Yamamoto, Takeshi
    Ito, Yasuki
    Hirano, Tsutomu
    CARDIOVASCULAR DIABETOLOGY, 2017, 16
  • [46] Dapagliflozin decreases small dense low-density lipoprotein-cholesterol and increases high-density lipoprotein 2-cholesterol in patients with type 2 diabetes: comparison with sitagliptin
    Toshiyuki Hayashi
    Tomoyasu Fukui
    Noriko Nakanishi
    Saki Yamamoto
    Masako Tomoyasu
    Anna Osamura
    Makoto Ohara
    Takeshi Yamamoto
    Yasuki Ito
    Tsutomu Hirano
    Cardiovascular Diabetology, 16
  • [47] Small dense low density lipoprotein predominance in patients with type 2 diabetes mellitus using Mendelian randomization
    Zhang, Fengyi
    Zhang, Yufeng
    Zhang, Jiayi
    Wang, Xin
    Li, Yujie
    Wang, Wenbo
    PLOS ONE, 2024, 19 (02):
  • [48] Beyond low-density lipoprotein: Addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome
    Nesto R.W.
    American Journal of Cardiovascular Drugs, 2005, 5 (6) : 379 - 387
  • [49] Low-Density Neutrophils Contribute to Subclinical Inflammation in Patients with Type 2 Diabetes
    Dumont, Benjamin L.
    Neagoe, Paul-Eduard
    Charles, Elcha
    Villeneuve, Louis
    Tardif, Jean-Claude
    Rakel, Agnes
    White, Michel
    Sirois, Martin G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (03)
  • [50] Autoantibodies to oxidized low-density lipoprotein in patients with Type 2 diabetes mellitus
    Hsu, RM
    Devaraj, S
    Jialal, I
    CLINICA CHIMICA ACTA, 2002, 317 (1-2) : 145 - 150
12345